REFERENCES
- Nix DE, Schentag JJ. The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharma-codinamics. J Clin Pharmacol 1988; 28: 169–178.
- Von Rosenstiel N, Adam D. Quinolone antibacterials - an update of their pharmacology and therapeutic use. Drugs 1993; 47: 371–401.
- Dagan R. Fluoroquinolones in paediatrics-1995. Drugs 1995; 49(S2): 92–99.
- Van der Oever HLA, Versteegh FGA, Thewessen EAPM, van den Anker JN, Mouton JW, Neijens HJ. Ciprofloxacin in preterm neonates: case report and review of the literature. Eur J Pediatr 1998; 157: 843–845.
- Shaad UB. Use of the quinolones in paediatrics. Drugs 1993; 45 (S3): 37–41.
- Mangiarotti P, Pizzini C, Fanos V. Antibiotic prophylaxis in children with relapsing urinary tract infections. J Chemother 2000; 12 (2): 115–123.
- Lietman PS. Fluorquinolone toxicities. An update. Drugs 1995; 49 (S2): 159–163.
- Christ W, Lehnert T, Uklbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988; 10: 141–146.
- Danisovicovà A, Krcmeryova T, Belan S, et al. Magnetic resonance imaging in diagnosis of potential arthropathogenici-ty in children receiving quinolones. No evidence of quinolone-induced arthropathy. Drugs 1995; 49 (S2): 492–494.
- Hooper DC, Wolfson JS. The fluoroquinolones: pharmacology, clinical uses and toxicities in humans. Antimicrob Agents Chemother 1985; 28: 716–721.
- Lode H. Pharmacokinetics and clinical results of par-enterally administered new quinolones in humans. Rev Infect Dis 1989; 11(S5): 996–1004.
- Valdvogel FA. Clinical role of the quinolones today and in the future. Eur J Clin Microbiol Infect Dis 1989; 8: 1075–1079.
- Norrby SR. Side-effects of quinolones: comparisons between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis 1991; 10 (4): 378–383.
- Peltola H, Vaarala M, Renkonen O, Neuvonen PJ. Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children. Antimicrob Agents Chemother 1992; 36 (5): 1086–1090.
- Bethell DB, Day NPJ, Dung NM, et al. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. Antimicrob Agents Chemother 1996; 40 (9): 2167–2172.
- Rubio TT, Miles MV, Church DA, Echols RM, Pickerin LK. Pharmacokinetic studies of ciprofloxacin in children with cystic fibrosis. Pediatr Res 1994; 35: 195A.
- Smith AL, Weber A, Pandher R, Williams-Warren J, Cohen ML, Ramsey B. Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis. Infection 1997; 25 (2): 106–108.
- Peltola H, Ukkonen P, Saxen H, Stass H. Single-dose and steady-state pharmacokinetics of a new oral suspension of ciprofloxacin in children. Pediatrics 1998; 101 (4Pt1): 658-662.
- Brun P. Utlization des quinolones dans le traitment des infectiones urinaires de l'enfant. In: Quinolones en pediatrie. Flammarion Medicine Sciences, 1992; 99–104.
- Fanos V, Khoory BJ. Antimicrobial survey of urinary tract isolates in paediatrics. J Chemother 1999; 11 (4): 255–259.
- Fujii R. The use of norfloxacin in children in Japan. Adv Antimicrob Antineopl Chemother 1992; 11-2: 219-230.
- Van Wijk JAE, de Jong TPVM, Van Cool JD. Using quinolones in urinary tract infections in children. Adv Antimicrob Antineopl Chemother 1992; 11-2: 157-161.
- Kaloyanides CJ. Antibiotic-related nephrotoxicity. Nephrol Dial Transpl 1994; 9 (S4): 130–134.
- Fanos V, Cataldi L. Antibacterial-induced nephrotoxicity in the newborn. Drug Safety 1999; 20 (3): 245–267.
- Hootkins R, Fenves AZ, Stephens MK. Acute renal fail-ure secondary to oral ciprofloxacin therapy: a presentation of three cases and review of the literature. Clin Nephrol 1989; 32: 75–78.
- Lien YH, Hansen R, Kern WF. Ciprofloxacin-induced granulomatous interstitial nephritis and localized elastolysis. Am J Kidney Dis 1993; 22: 598–602.
- Dharnidharka VR, Nadeau K, Cannon CL. Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis 1998; 31: 481–485.
- AlIon M, Lopez EJ, Min KW. Acute renal failure due to ciprofloxacin. Arch Intern Med 1990; 150: 2187–2189.
- Blum MD, Graham DJ, McClosey CA. Temafloxacin syndrome: review of 95 cases. Clin Infect Dis 1994; 18: 946–950.
- Thorsteinsson SB, Bergan T, Oddsdottir S, et al. Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy 1986; 32: 408–417.
- Paton JH, Reeves DS. Clinical features and manage-ment of adverse effects of quinolone antibacterials. Drug Safe-ty 1991; 6 (1): 8–27.